Gilead announces PURPOSE 2 met efficacy endpoints, reduced HIV infections by 96%

MLA

“Gilead Announces PURPOSE 2 Met Efficacy Endpoints, Reduced HIV Infections by 96%.” The Fly, Sept. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.808437706&authtype=sso&custid=ns315887.

APA

Gilead announces PURPOSE 2 met efficacy endpoints, reduced HIV infections by 96%. (2024, September 12). The Fly.

Chicago

The Fly. 2024. “Gilead Announces PURPOSE 2 Met Efficacy Endpoints, Reduced HIV Infections by 96%,” September 12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.808437706&authtype=sso&custid=ns315887.